Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 115,694,154
- Total 13F shares
- 1,209,905
- Share change
- +349,203
- Total reported value
- $1,701,000
- Price per share
- $1.41
- Number of holders
- 13
- Value change
- +$495,636
- Number of buys
- 7
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92686J106:
Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC |
13F
|
Company |
0.48%
|
554,382
|
$699,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.18%
|
205,575
|
$259,000 | — | 30 Jun 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
31,264
|
$39,000 | — | 30 Jun 2016 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
20,300
|
$25,000 | — | 30 Jun 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,962
|
$21,000 | — | 30 Jun 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
16,624
|
$21,000 | — | 30 Jun 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,250
|
$8,000 | — | 30 Jun 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,252
|
$4,000 | — | 30 Jun 2016 | |
| Acrospire Investment Management LLC |
13F
|
Company |
0%
|
2,300
|
$3,000 | — | 30 Jun 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,807
|
$2,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
728
|
$1,000 | — | 30 Jun 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
646
|
$1,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
595
|
$1,000 | — | 30 Jun 2016 |
Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q3 2016
As of 30 Sep 2016,
Viking Therapeutics, Inc. - Common Stock (VKTX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,209,905 shares.
The largest 10 holders included
Sio Capital Management, LLC, VANGUARD GROUP INC, GRT CAPITAL PARTNERS L.L.C., GEODE CAPITAL MANAGEMENT, LLC, KCG Holdings, Inc., RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, WELLS FARGO & COMPANY/MN, Acrospire Investment Management LLC, and MANUFACTURERS LIFE INSURANCE COMPANY, THE.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
12
Q3 2016 holders
13
Holder diff
1
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.